Evaluation of the long-term cost-effectiveness of IDegLira versus liraglutide added to basal insulin for patients with type 2 diabetes failing to achieve glycemic control on basal insulin in the USA.
about
Evaluation of the long-term cost-effectiveness of IDegLira versus liraglutide added to basal insulin for patients with type 2 diabetes failing to achieve glycemic control on basal insulin in the USA.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Evaluation of the long-term co ...... l on basal insulin in the USA.
@en
type
label
Evaluation of the long-term co ...... l on basal insulin in the USA.
@en
prefLabel
Evaluation of the long-term co ...... l on basal insulin in the USA.
@en
P2093
P2860
P1476
Evaluation of the long-term co ...... l on basal insulin in the USA.
@en
P2093
P2860
P304
P356
10.1080/13696998.2017.1301943
P407
P577
2017-03-03T00:00:00Z